About Us

About

about cellserve

About Us

We are a team of experts with over 30 years of experience in hematopoietic stem cell transplantation and cellular therapy.

Together, we can guide your clinic through infrastructure requirements, clinical operations, quality and regulatory compliance.

Our passion is making health care innovation accessible to everyone. We want to make cell therapy a reality for everyone who needs it, in the United States and around the world. We believe that no one should die from treatable causes.

It is extremely difficult to transform community health care centers into centers that can provide cellular therapy safely. We know how to do it. The only way is having the right expertise.

What we offer is a level and depth of guidance that cannot be acquired overnight, in a week, or even a year. It cannot be replaced by a checklist. Our team has grown and evolved alongside cellular therapy, all the way from hematopoietic transplantation to CAR T-cells.

Our Vision

A world with universal access to health care innovation, where we eliminate death from treatable causes.

Our Mission

Making healthcare advances and innovation immediately accessible to everyone – closer to home – thereby overcoming geographic, social, and economic barriers.

Values

Integrity

Our Promise to Patients

Accountability

Diversity and Inclusion

Together, we fully cover all aspects of the expertise you need.

Our Team

your partners in innovation

CellServe is comprised of premier researchers and hematologists/oncologists. We are a team with unique, complementary, and synergistic skills honed during years of experience in the field.

About Us CellServe Daniel Couriel

Daniel Couriel

MD, MS, MBA
Founder
Dr. Couriel is an expert in operational organization and quality in all aspects of cellular therapy. He has worked in the Foundation for Accreditation of Cellular Therapy (FACT) for over 20 years and is now on their Board of Directors and chairs the Task Force for New Business Development.
About Us CellServe

Alayna Williamson

MBA
Chief Executive Officer

Ms. Williamson has over 20 years of leadership and business management experience with expertise in healthcare finance, scaling complex projects and organizations, and providing optimal cancer patient care.

About Us CellServe

Marcos De Lima

MD
Chief Medical Officer

Dr. De Lima has been instrumental in developing and facilitating the manufacturing of CAR T-cells at points of care in the U.S. and globally. He has been a dedicated clinician, clinical investigator, and leader in the field of Hematopoietic Stem Cell Transplantation (HSCT) for over 30 years.

About Us CellServe

David Wald

MD, PhD
Chief Scientific Officer

Dr. Wald pioneers cutting-edge manufacturing technologies in his laboratory, including CAR T-cells and other products that are not only intended to improve outcomes and tolerance of cellular therapy, but to broaden access to these products.